Skip to main content
Glenmark Pharmaceuticals declines 13% in two days on profit booking - Business Standard 25-Jun-2020
Glenmark Pharmaceuticals declines 13% in two days on profit booking - Business Standard
The stock has jumped 40 per cent in the intra-day trade on Monday after the firm received approval for Favipiravir's (Fabiflu), a potential Covid-19 drug, by the Drug Controller General of India
More...